Advances in cancer treatments have led to an increasing number of cancer survivors, but
also high rates of short-and long-term cardiovascular (CV) toxicities. The number of new …

Cardiovascular disease (CVD) and cancer persist as the primary contributors to global
mortality. Knowledge of cancer and cancerrelated therapies leading to CVD has laid the …

Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-Oncology: From Basic
Research to Advanced Study analyzes the emerging the field of cardio-oncology, reviewing …

The aging population and improvements in cancer detection and treatment have contributed
to a growing population of cancer survivors. There were approximately 1.9 million newly …

The therapeutical advances in recent years in the field of oncology treatment have increased
survival rates and improved the quality of life of oncology patients, thus turning cancer into a …

Through the success of basic and disease-specific research, cancer survivors are one of the
largest growing subsets of individuals accessing the healthcare system. Interestingly …

Cardio-oncology is a subspecialty of cardiology. It was created to address oncology data
indicating that newly developed drugs for cancer treatment were having unanticipated …

In November 2009, the first cardiac catheterization laboratory in a cancer center in the world
was opened at The University of Texas MD Anderson Cancer Center. With it surfaced a new …

© 2023 Bisceglia, Canale, Gallucci, Turazza, Lestuzzi, Parrini, Russo, Maurea, Quagliariello,
Oliva, Angela Di Fusco, Lucà, Tarantini, Trambaiolo, Moreo, Geraci, Gabrielli, Gulizia, Oliva …

Improvements in early diagnosis and cancer treatments have contributed to high survival
rates for many cancer patients. However, these patients often die of cardiovascular disease …